Global Biomarkers Market 2022-2028

May 2022 | 82 pages | ID: GE18FD9DDBF5EN
Gen Consulting Company

Abstracts

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention. Examples include patterns of gene expression, levels of a particular protein in body fluids, or changes in electrical activity in the brain. The global biomarkers market is likely to register a CAGR of over 12.3% with an incremental growth of USD 48 billion during the forecast period 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biomarkers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biomarkers industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, disease, end user, and region. The global market for biomarkers can be segmented by product: consumables, instruments, services, software. Among these, the consumables segment was accounted for the highest revenue generator in 2021. Biomarkers market is further segmented by technology: genomics, proteomics, metabolomics, imaging, others. The proteomics segment is estimated to account for the largest share of the global biomarkers market. Based on disease, the biomarkers market is segmented into: cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, others. The cancer segment held the largest share of the global biomarkers market in 2021 and is anticipated to hold its share during the forecast period. On the basis of end user, the biomarkers market also can be divided into: biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes. In 2021, the hospitals and diagnostics segment made up the largest share of revenue generated by the biomarkers market. Biomarkers market by region is categorized into: Emerging Region, Europe, North America.

By product:

• consumables
• instruments
• services
• software

By technology:

• genomics
• proteomics
• metabolomics
• imaging
• others

By disease:

• cancer
• cardiovascular and metabolic diseases
• neurodegenerative diseases
• infectious diseases
• autoimmune diseases
• others

By end user:

• biopharmaceutical and biotech companies
• CROs
• hospitals and diagnostics
• research and academic institutes

By region:

• Emerging Region
• Europe
• North America

The market research report covers the analysis of key stake holders of the global biomarkers market. Some of the leading players profiled in the report include Abbott Laboratories Inc., Agilent Technologies Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., Bruker Corp., Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd, FUJIFILM VisualSonics Inc., GE Healthcare, Illumina, Inc., JEOL Ltd., Koninklijke Philips N.V., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., QIAGEN N.V., Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global biomarkers market.
• To classify and forecast the global biomarkers market based on product, technology, disease, end user, region.
• To identify drivers and challenges for the global biomarkers market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biomarkers market.
• To identify and analyze the profile of leading players operating in the global biomarkers market.

Why Choose This Report

• Gain a reliable outlook of the global biomarkers market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY PRODUCT

Consumables
Instruments
Services
Software

PART 6. MARKET BREAKDOWN BY TECHNOLOGY

Genomics
Proteomics
Metabolomics
Imaging
Others

PART 7. MARKET BREAKDOWN BY DISEASE

Cancer
Cardiovascular and metabolic diseases
Neurodegenerative diseases
Infectious diseases
Autoimmune diseases
Others

PART 8. MARKET BREAKDOWN BY END USER

Biopharmaceutical and biotech companies
CROs
Hospitals and diagnostics
Research and academic institutes

PART 9. MARKET BREAKDOWN BY REGION

Emerging Region
Europe
North America

PART 10. KEY COMPANIES

Abbott Laboratories Inc.
Agilent Technologies Inc.
Bayer AG
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corp.
Bruker Corp.
Canon Medical Systems Corporation
Danaher Corporation
F. Hoffmann-La Roche Ltd
FUJIFILM VisualSonics Inc.
GE Healthcare
Illumina, Inc.
JEOL Ltd.
Koninklijke Philips N.V.
Oxford Nanopore Technologies Limited
PerkinElmer, Inc.
QIAGEN N.V.
Shimadzu Corporation
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Waters Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER